My word! Government bureaucracy is inefficient!

Thousands of patients suffering from cancer and other serious illnesses are being denied the drugs they need from the NHS, according to a report.

Even though the treatments have been approved by the health service rationing body, at least 14,000 patients a year are not receiving them.

As many as one in three of those suffering from some types of cancer are going without medication that could extend their lives, the figures show.

This is a surprise, isn’t it?

4 thoughts on “My word! Government bureaucracy is inefficient!”

  1. Haven’t you got this arse over tip, Tim? NICE says that a drug may be prescribed on the NHS; it’s not its job to balance the budgets of “local NHS bodies” nor to insist that doctors prescribe any particular drug. In other words, it may have bugger all to do with bureaucracy being inefficient.

  2. I shall try to phrase this carefully…

    Where an activity is a cost with no revenue potential financed out of a fixed budget with external pressure to meet it, such pressure passed on internally, the cheapest course is not to carry out the activity at all, particularly if carrying out the activity will result in recurring activity, or limit the number of activities, or to move the activity onto a different budget.

    It would be naive to imagine that an institution preoccupied with self-preservation, insulated from the consequences of its actions and inactions, somewhat precious about its image, schooled to deflect blame externally when criticised, will not develop a climate in which such a policy can arise, subconsciously carried out by those within it.

  3. The report suggests that the NHS has very efficiently managed to treat 148% of the projected number of dementia patients. On the other hand, it has inefficiently reached only 68% of renal cell carcinoma patients. My guess is that the statistic methods employed aren’t accurate enough to tell us anything much. In particular, for renal cell carcinoma patients, I’d like to know what proportion of patients are in clinical trials comparing various treatment regimes using the latest drugs, for which the drug supply is not counted in these statistics “this dataset excludes use of the drug in clinical trials”.

Leave a Reply

Your email address will not be published. Required fields are marked *